StockDriftsStockDriftsTop 1 Lilly Endowment INC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | 100% | 90.07M | $104.21B | -0.34%(-310.00K) | $36.15(+3331.09%) | 2026-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +29.15% | +115.42% | +38.02% | +400.79% |
| Top 20 Holdings Unweighted | +29.15% | +115.42% | +38.02% | +400.79% |
Lilly Endowment INC reports $104.21B in US-listed equity holdings across 1 position in its most recent 13F filing. Its largest disclosed position is LLY (100.0%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +115.42% on a three-year cumulative basis. Figures reflect the Q3 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Lilly Endowment INC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Lilly Endowment INC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 316011). View Lilly Endowment INC’s 13F filings on SEC